Random header image... Refresh for more!

Novartis Still On Track to Buy Majority In Alcon

by Editor

Novartis Chief Executive Daniel Vasella confirmed that Novartis is still on track to buy a majority share in Alcon in a report December 5, 2008 in Switzerland

Bookmark and Share

Related posts:

  1. From Allergan To Advanced Medical Optics To Abbott In 7 Years
  2. Alcon second-quarter profit rises 26 pct
  3. Dan Pritchard – International Pharmaceuticals and Medical Device Industries Management Consultant
  4. BD (Becton Dickinson) On A Roll
  5. Cuts to HME: Reform report leaves door ‘wide open’ – HME News

1 comment

1 From Allergan To Advanced Medical Optics To Abbott In 7 Years — the international medical market place { 01.12.09 at 11:56 pm }

[...] Makes sense with one possible caveat – ophthalmology requires focus and the most successful companies have been largely independent. This changes with the Abbott acquisition, but also comes short on the heels of the new majority shareholding by Novartis in Alcon… [...]

Leave a Comment